Gooitzen Michell van Dam

Prof. Gooitzen Michell van Dam is a Professor at the University of Groningen's Faculty of Medical Sciences, specializing in surgical oncology and molecular imaging. He holds leadership roles including CEO of TRACER Europe BV (a clinical research organization) and Founding Member of the European Society of Molecular Imaging. His research focuses on optical and nuclear molecular imaging, tracer development, micro-dosing, and clinical translation in oncology, infectious diseases, and cardiovascular imaging.

• Education: Not explicitly detailed in provided texts

Key research areas include EGFR-targeted fluorescence imaging, laser speckle contrast imaging for perfusion assessment, and SARS-CoV-2 vaccine development. His work bridges surgical innovation with molecular imaging technologies, aiming to improve diagnostic accuracy and treatment outcomes. Prof. van Dam has led multinational clinical trials and contributed to over 218 publications, with recent focus on vaccine efficacy, surgical guidance systems, and perfusion monitoring.

He collaborates with industry through TRACER Europe BV, advancing translational research and imaging solutions. Notably, his team developed dye-free perfusion imaging tools and explored novel vaccine strategies for global health equity.